Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. [electronic resource]
- Free radical research Apr 2008
- 397-404 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1029-2470
10.1080/10715760801998646 doi
Animals Antioxidants--pharmacology Diabetes Mellitus, Experimental--drug therapy Diabetic Nephropathies--prevention & control Histones--chemistry Male Oxidative Stress Phosphorylation Rats Rats, Sprague-Dawley Resveratrol Sirtuin 1 Sirtuins--metabolism Stilbenes--pharmacology Streptozocin--pharmacology Tumor Suppressor Protein p53--metabolism p38 Mitogen-Activated Protein Kinases--metabolism